| [1] Bodmer M1,Meier C,Krähenbühl S,et al.Long-term metformin use is associated with decreased risk of breast cancer[J].Diabetes Care,2010,33(6):1304-1308.[2] Junmei M.Excess body weight and cancer risk in patients with type 2 diabetes who were registered in Swedish national diabetes register-register-based cohort study in Sweden[J].PLoS One,2014,9(9):e105868.[3] Wu AH,Kurian AW,KwanML,et al.Diabetes and other comorbidities in breast cancer survival by race/ethnicity:the California breast cancer survivorship consortium[J].Cancer Epidemiol Biomarkers Prev,2015,24(2):361-368.[4] Jiralerspong S,Palla SL,Giordano SH,et al.Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer[J].J Clin Oncol,2009,27(20):3297-3302.[5] Queiroz EA,Puukila S,Eichler R,et al.Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress,AMPK and FOXO3a in MCF-7 breast cancer cells[J].PLoS One,2014,9(5):e98207.[6] Dowling RJ,Zakikhani M,Fantus IG,et al.Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells[J].Cancer Res,2007,67(22):10804-10812.[7] Dowling RJ,Niraula S,Chang MC,et al.Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer:a prospective window of opportunity neoadjuvant study[J].Breast Cancer Res,2015,17(1):32.[8] Pollak MN.Insulin,insulin-like growth factors,insulin resistance,and neoplasia[J].Am J Clin Nutr,2007,86(3):820-822.[9] Wahdan-Alaswad RS,Cochrane DR,Spoelstra NS,et al.Metformin-induced killing of triple negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b[J].Horm Cancer,2014,5(6):374-389.[10] Liu B,Fan Z,Edgerton SM,et al.Metformin induces unique biological and molecular responses in triple negative breast cancer cells[J].Cell Cycle,2009,8(13):2031-2040.[11] DeCensi A,Puntoni M,Gandini S,et al.Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial[J].Breast Cancer Res Treat,2014,148:81-90.[12] Lgire C,Amrein L,Bazile M,et al.Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo[J].Oncogene,2011,30(10):1174-1182.[13] Jeon SM.AMPK regulates NADPH homeostasis to promote tumour cell survival during energystress[J].Nature,2012,485(7400):661-665.[14] Silvestri A,Palumbo F,Rasi I,et al.Metformin induces apoptosis and downregulates pyruvate kinase M2 in breast cancer cells only when growninnutrient-poorconditions[J].PLoS One,2015,10(8):e0136250.[15] Sanchez-Alvarez R,Martinez-Outschoorn UE,Lamb R,et al.Mitochondrial dysfunction in breast cancer cells prevents tumor growth:Understanding chemoprevention with metformin[J].Cell Cycle,2013,12(1):172-182.[16] Niraula S,Dowling RJ,Ennis M,et al. Metformin in early breast cancer:a prospective window of opportunity neoadjuvant study[J].Breast Cancer Res Treat,2012,135(3):821-830.[17] Bonanni B,Puntoni M,Cazzaniga M,et al.Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial[J].J Clin Oncol,2012,30(21):2593-2600.[18] Zhu P,Davis M,Blackwelder AJ,et al.Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models[J].Cancer Prev Res (Phila),2014,7(2):199-210.[19] Ma J,Guo Y,Chen S,et al.Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma[J].BMC Cancer,2014,14:172. |
